RA Capital Management, L.P. 13D and 13G filings for Aerovate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-06-20 6:00 pm Purchase | 2024-06-17 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 264,060 32.000% | 26,517![]() (+11.16%) | Filing |
2024-04-30 4:16 pm Purchase | 2024-04-26 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 237,542 28.900% | 595![]() (+0.25%) | Filing |
2023-06-27 5:00 pm Purchase | 2023-06-26 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 236,947 30.000% | 833![]() (+0.35%) | Filing |
2021-07-12 5:13 pm Purchase | 2021-07-02 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 236,114 33.900% | 236,114![]() (New Position) | Filing |